Haemorrhage, Shock & Blood Products
Recognise concealed bleeding and understand why resuscitation must accompany prompt haemorrhage control.
20 learning units • 100 chapter sections • 200 explained questions. Assess surgical disease, recognise complications and connect intervention with safe recovery and follow-up.
Recognise concealed bleeding and understand why resuscitation must accompany prompt haemorrhage control.
Quick revision ↓ Medical Dictionary
Tachycardia, cool peripheries, altered mentation, reduced urine output and rising lactate can indicate shock before marked hypotension. Beta-blockers, age and other factors can modify expected signs. Consider haemorrhagic, distributive, cardiogenic and obstructive mechanisms, including combinations. The response to initial treatment is important evidence, but a transient improvement does not establish that bleeding has stopped or that transfer is safe.
In trauma, blood may be concealed in the chest, abdomen, retroperitoneum, pelvis or injured limbs. After surgery, consider the operative site, drains, gastrointestinal loss and internal collections. Quantified visible loss can underestimate total haemorrhage. Check anticoagulants and procedure details while arranging source-control assessment. A normal early haemoglobin concentration does not reliably exclude significant acute blood loss.
Major haemorrhage requires a team response, access, warming, rapid testing and an appropriate blood-product pathway. Balanced resuscitation follows local protocols and changes with laboratory or point-of-care results. Avoid repeated large crystalloid volumes as the sole response to uncontrolled bleeding. Definitive haemostasis may require surgery, endoscopy or interventional radiology; resuscitation buys time but does not repair the source.
Hypothermia, acidosis and coagulopathy can amplify bleeding. Monitor calcium and electrolytes during substantial transfusion and reassess clotting and platelets. If a transfusion reaction is suspected, stop the transfusion and follow the emergency investigation and support pathway. Do not assume every deterioration during transfusion is caused by the original illness. Patient identification and product checks remain essential under time pressure.
Track perfusion, urine output, mental state, haemoglobin trends and continuing losses. Rebleeding and organ injury remain possible after a reassuring first response. Explain the plan to the patient or family when feasible and document blood products and treatment decisions. After recovery, review anaemia, transfusion indications and the cause of bleeding so discharge addresses more than the final haemoglobin number.
Read the relevant guideline sections alongside these original clinical teaching cases. Local pathways, available services and individual patient factors determine care.
Reference review: 27 September 2026. Consult current local protocols for prescribing, procedures and escalation.